Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ANVS

Annovis Bio (ANVS)

Annovis Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:ANVS
DateTimeSourceHeadlineSymbolCompany
01/04/202423:00GlobeNewswire Inc.Annovis Announces Publication That Supports Understanding of Buntanetap’s Mechanism of Action in HumansAMEX:ANVSAnnovis Bio Inc
20/03/202422:30GlobeNewswire Inc.Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer’s DiseaseAMEX:ANVSAnnovis Bio Inc
28/02/202400:00GlobeNewswire Inc.Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024AMEX:ANVSAnnovis Bio Inc
14/02/202423:30GlobeNewswire Inc.Annovis Bio Announces Last Patient Last Visit in the Phase II/III Study of Buntanetap in Alzheimer’s DiseaseAMEX:ANVSAnnovis Bio Inc
31/01/202400:00GlobeNewswire Inc.Annovis Bio Announces the Filing of New Patent Application for Treatment of Mental Illnesses Expanding the Company’s PortfolioAMEX:ANVSAnnovis Bio Inc
25/01/202400:00GlobeNewswire Inc.Annovis Bio Refines Timeline for Parkinson’s Phase III Study Data AnnouncementAMEX:ANVSAnnovis Bio Inc
12/12/202305:00GlobeNewswire Inc.Annovis Bio to Participate in the 139th Yale CEO SummitAMEX:ANVSAnnovis Bio Inc
05/12/202323:30GlobeNewswire Inc.Annovis Bio Announces Last Patient Last Visit in the Phase III Study of Buntanetap in Parkinson’s DiseaseAMEX:ANVSAnnovis Bio Inc
01/12/202323:30GlobeNewswire Inc.Annovis Bio Appoints Andrew Walsh as Vice President FinanceAMEX:ANVSAnnovis Bio Inc
27/11/202323:30GlobeNewswire Inc.Annovis Bio Announces Full Enrollment of Its Phase II/III Alzheimer’s Disease Trial, Exceeding Original ProjectionsAMEX:ANVSAnnovis Bio Inc
09/11/202309:00GlobeNewswire Inc.Annovis Bio Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateAMEX:ANVSAnnovis Bio Inc
12/10/202323:02GlobeNewswire Inc.Annovis Bio Announces Positive Interim Independent Analysis for Statistical Power in Its Alzheimer’s StudyAMEX:ANVSAnnovis Bio Inc
17/06/202306:19Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
31/05/202307:20Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
11/05/202306:35Edgar (US Regulatory)Quarterly Report (10-q)AMEX:ANVSAnnovis Bio Inc
28/04/202322:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:ANVSAnnovis Bio Inc
27/04/202306:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
25/04/202320:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:ANVSAnnovis Bio Inc
04/04/202307:29Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
03/04/202321:53Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
01/04/202300:19Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
09/02/202309:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
21/01/202309:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
21/01/202309:43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
21/01/202309:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
21/01/202309:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
21/01/202309:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
07/01/202308:06Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
09/11/202208:45Edgar (US Regulatory)Quarterly Report (10-q)AMEX:ANVSAnnovis Bio Inc
13/09/202207:10Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
 Showing the most relevant articles for your search:AMEX:ANVS